CIRCULAR OF INFORMATION FOR THE USE OF CELLULAR THERAPY PRODUCTS The online version of this Circular of Information is provided for educational purposes. Printed copies of the Circular are intended to accompany cellular

First Page		Document Content
Date: 2010-06-02 13:47:05 Stem cells Hematology Transplantation medicine Childbirth Cord blood Hematopoietic stem cell transplantation Cell therapy Apheresis Blood donation Medicine Biology Transfusion medicine		CIRCULAR OF INFORMATION FOR THE USE OF CELLULAR THERAPY PRODUCTS The online version of this Circular of Information is provided for educational purposes. Printed copies of the Circular are intended to accompany cellular Add to Reading List Source URL: www.aatb.org Download Document from Source Website File Size: 386,37 KB Share Document on Facebook

	Sickle cell disease and hyperhemolysis: epidemiology, risk factors and new therapeutic approaches in France WORLD APHERESIS ASSOCIATION AND FRENCH SOCIETY FOR HEMAPHERESIS April 27-29, 2016, PARIS-FRANCE DocID: 1sjCl - View Document
	Who can make an apheresis donation? To qualify, donors must meet all required blood donation standards, including: • Be at least 17 years old. Donors under the age Making an apheresis donation is DocID: 1rrmk - View Document
	S7 KHOEL Manual exchanges WAA DocID: 1rnBM - View Document
	HemaT symposium Rheopheresis and distal arteriopathy [Mode de compatibilité] DocID: 1rnak - View Document
	Prediction Algorithms for Cell Therapy Collections, J. Roig WAA 2016 DocID: 1rhi1 - View Document